Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Exercise therapy across the prostate cancer continuum

Prostate Cancer and Prostatic Diseases volume 12, pages 110–115 (2009)Cite this article

Abstract

Exercise has been increasingly investigated as an adjunct therapy for cancer patients. The purpose of this paper is to comprehensively review the literature regarding exercise as a therapeutic adjunct for prostate cancer (PC). Several studies in patients with PC have shown quality of life improvements associated with exercise. Although no study has established the effect of exercise as a monotherapy for PC, the molecular mechanisms responsible for the potential association between exercise and PC are being elucidated. Given the low-risk, high-reward nature of these studies, further investigations are needed to better define the function of exercise along the PC continuum.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gacci M, Lapini A, Serni S, Livi L, Paiar F, Detti B et al. Predictors of quality of life after radical treatment for prostate cancer. Urol Int 2008; 80: 231–236.

    Article  PubMed  Google Scholar 

  2. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR . Management of complications of prostate cancer treatment. CA Cancer J Clin 2008; 58: 196–213.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250–1261.

    Article  CAS  PubMed  Google Scholar 

  4. Shah JB, McKiernan JM, Elkin EP, Carroll PR, Meng MV . Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol 2008; 179: 136–140.

    Article  PubMed  Google Scholar 

  5. Hamilton RJ, Aronson WJ, Presti Jr JC, Terris MK, Kane CJ, Amling CL et al. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer 2007; 110: 2202–2209.

    Article  CAS  PubMed  Google Scholar 

  6. Basaria S, Lieb II J, Tang AM, DeWeese T, Carducci M, Eisenberger M et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) 2002; 56: 779–786.

    Article  CAS  Google Scholar 

  7. Smith MR . Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 2004; 63: 742–745.

    Article  PubMed  Google Scholar 

  8. Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM . Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005; 90: 6410–6417.

    Article  CAS  PubMed  Google Scholar 

  9. Tsai HK, D’Amico AV, Sadetsky N, Chen MH, Carroll PR . Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 2007; 99: 1516–1524.

    Article  PubMed  Google Scholar 

  10. Saigal CS, Gore JL, Krupski TL, Hanley J, Schonlau M, Litwin MS . Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 2007; 110: 1493–1500.

    Article  CAS  PubMed  Google Scholar 

  11. D’Amico AV, Denham JW, Crook J, Chen MH, Goldhaber SZ, Lamb DS et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 2007; 25: 2420–2425.

    Article  CAS  PubMed  Google Scholar 

  12. Keating NL, O’Malley AJ, Smith MR . Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006; 24: 4448–4456.

    Article  CAS  PubMed  Google Scholar 

  13. Oh WK, Small EJ . Complementary and alternative therapies in prostate cancer. Semin Oncol 2002; 29: 575–584.

    Article  PubMed  Google Scholar 

  14. Warburton DE, Nicol CW, Bredin SS . Health benefits of physical activity: the evidence. CMAJ 2006; 174: 801–809.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Andersson SO, Baron J, Wolk A, Lindgren C, Bergstrom R, Adami HO . Early life risk factors for prostate cancer: a population-based case–control study in Sweden. Cancer Epidemiol Biomarkers Prev 1995; 4: 187–192.

    CAS  PubMed  Google Scholar 

  16. Bairati I, Larouche R, Meyer F, Moore L, Fradet Y . Lifetime occupational physical activity and incidental prostate cancer (Canada). Cancer Causes Control 2000; 11: 759–764.

    Article  CAS  PubMed  Google Scholar 

  17. Brownson RC, Chang JC, Davis JR, Smith CA . Physical activity on the job and cancer in Missouri. Am J Public Health 1991; 81: 639–642.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Clarke G, Whittemore AS . Prostate cancer risk in relation to anthropometry and physical activity: the National Health and Nutrition Examination Survey I Epidemiological Follow-Up Study. Cancer Epidemiol Biomarkers Prev 2000; 9: 875–881.

    CAS  PubMed  Google Scholar 

  19. Hartman TJ, Albanes D, Rautalahti M, Tangrea JA, Virtamo J, Stolzenberg R et al. Physical activity and prostate cancer in the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study (Finland). Cancer Causes Control 1998; 9: 11–18.

    Article  CAS  PubMed  Google Scholar 

  20. Lund Nilsen TI, Johnsen R, Vatten LJ . Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer 2000; 82: 1358–1363.

    Article  CAS  PubMed  Google Scholar 

  21. Norman A, Moradi T, Gridley G, Dosemeci M, Rydh B, Nyren O et al. Occupational physical activity and risk for prostate cancer in a nationwide cohort study in Sweden. Br J Cancer 2002; 86: 70–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Oliveria SA, Kohl III HW, Trichopoulos D, Blair SN . The association between cardiorespiratory fitness and prostate cancer. Med Sci Sports Exerc 1996; 28: 97–104.

    Article  CAS  PubMed  Google Scholar 

  23. Paffenbarger Jr RS, Hyde RT, Wing AL . Physical activity and incidence of cancer in diverse populations: a preliminary report. Am J Clin Nutr 1987; 45 (1 Suppl): 312–317.

    Article  PubMed  Google Scholar 

  24. Steenland K, Nowlin S, Palu S . Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995; 4: 807–811.

    CAS  PubMed  Google Scholar 

  25. Thune I, Lund E . Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 1994; 5: 549–556.

    Article  CAS  PubMed  Google Scholar 

  26. Vena JE, Graham S, Zielezny M, Brasure J, Swanson MK . Occupational exercise and risk of cancer. Am J Clin Nutr 1987; 45 (1 Suppl): 318–327.

    Article  CAS  PubMed  Google Scholar 

  27. Wannamethee SG, Shaper AG, Walker M . Physical activity and risk of cancer in middle-aged men. Br J Cancer 2001; 85: 1311–1316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Yu H, Harris RE, Wynder EL . Case–control study of prostate cancer and socioeconomic factors. Prostate 1988; 13: 317–325.

    Article  CAS  PubMed  Google Scholar 

  29. Friedenreich CM, McGregor SE, Courneya KS, Angyalfi SJ, Elliott FG . Case–control study of lifetime total physical activity and prostate cancer risk. Am J Epidemiol 2004; 159: 740–749.

    Article  CAS  PubMed  Google Scholar 

  30. Moore SC, Peters TM, Ahn J, Park Y, Schatzkin A, Albanes D et al. Physical activity in relation to total, advanced, and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 2458–2466.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Dosemeci M, Hayes RB, Vetter R, Hoover RN, Tucker M, Engin K et al. Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control 1993; 4: 313–321.

    Article  CAS  PubMed  Google Scholar 

  32. Giovannucci E, Leitzmann M, Spiegelman D, Rimm EB, Colditz GA, Stampfer MJ et al. A prospective study of physical activity and prostate cancer in male health professionals. Cancer Res 1998; 58: 5117–5122.

    CAS  PubMed  Google Scholar 

  33. Hsing AW, McLaughlin JK, Zheng W, Gao YT, Blot WJ . Occupation, physical activity, and risk of prostate cancer in Shanghai, People's Republic of China. Cancer Causes Control 1994; 5: 136–140.

    Article  CAS  PubMed  Google Scholar 

  34. Le Marchand L, Kolonel LN, Yoshizawa CN . Lifetime occupational physical activity and prostate cancer risk. Am J Epidemiol 1991; 133: 103–111.

    Article  CAS  PubMed  Google Scholar 

  35. Lee IM, Sesso HD, Paffenbarger Jr RS . A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control 2001; 12: 187–193.

    Article  CAS  PubMed  Google Scholar 

  36. Liu S, Lee IM, Linson P, Ajani U, Buring JE, Hennekens CH . A prospective study of physical activity and risk of prostate cancer in US physicians. Int J Epidemiol 2000; 29: 29–35.

    Article  CAS  PubMed  Google Scholar 

  37. Pukkala E, Kaprio J, Koskenvuo M, Kujala U, Sarna S . Cancer incidence among Finnish world class male athletes. Int J Sports Med 2000; 21: 216–220.

    Article  CAS  PubMed  Google Scholar 

  38. Putnam SD, Cerhan JR, Parker AS, Bianchi GD, Wallace RB, Cantor KP et al. Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 2000; 10: 361–369.

    Article  CAS  PubMed  Google Scholar 

  39. Severson RK, Nomura AM, Grove JS, Stemmermann GN . A prospective analysis of physical activity and cancer. Am J Epidemiol 1989; 130: 522–529.

    Article  CAS  PubMed  Google Scholar 

  40. Villeneuve PJ, Johnson KC, Kreiger N, Mao Y . Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 1999; 10: 355–367.

    Article  CAS  PubMed  Google Scholar 

  41. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87: 652–661.

    Article  CAS  PubMed  Google Scholar 

  42. Patel AV, Rodriguez C, Jacobs EJ, Solomon L, Thun MJ, Calle EE . Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol Biomarkers Prev 2005; 14: 275–279.

    Article  PubMed  Google Scholar 

  43. Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB et al. Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 1997; 8: 229–238.

    Article  CAS  PubMed  Google Scholar 

  44. Lacey Jr JV, Deng J, Dosemeci M, Gao YT, Mostofi FK, Sesterhenn IA et al. Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China. Int J Epidemiol 2001; 30: 341–349.

    Article  PubMed  Google Scholar 

  45. Sung JF, Lin RS, Pu YS, Chen YC, Chang HC, Lai MK . Risk factors for prostate carcinoma in Taiwan: a case–control study in a Chinese population. Cancer 1999; 86: 484–491.

    Article  CAS  PubMed  Google Scholar 

  46. West DW, Slattery ML, Robison LM, French TK, Mahoney AW . Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 1991; 2: 85–94.

    Article  CAS  PubMed  Google Scholar 

  47. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 2005; 174: 1065–1069; discussion 1069–1070.

    Article  PubMed  Google Scholar 

  48. Frattaroli J, Weidner G, Dnistrian AM, Kemp C, Daubenmier JJ, Marlin RO et al. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up. Urology 2008; 72: 1319–1323.

    Article  PubMed  Google Scholar 

  49. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C et al. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA 2008; 105: 8369–8374.

    Article  CAS  PubMed  Google Scholar 

  50. Alibhai SM, Leach M, Tomlinson G, Krahn MD, Fleshner N, Holowaty E et al. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 2005; 97: 1525–1532.

    Article  PubMed  Google Scholar 

  51. Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR et al. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer 2007; 110: 590–598.

    Article  PubMed  Google Scholar 

  52. Arthur HM, Daniels C, McKelvie R, Hirsh J, Rush B . Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial. Ann Intern Med 2000; 133: 253–262.

    Article  CAS  PubMed  Google Scholar 

  53. Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL . Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 2006; 296: 1851–1857.

    Article  CAS  PubMed  Google Scholar 

  54. Bhatnagar V, Stewart ST, Huynh V, Jorgensen G, Kaplan RM . Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment. Prostate Cancer Prostatic Dis 2006; 9: 136–146.

    Article  CAS  PubMed  Google Scholar 

  55. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000; 30: 328–338.

    Article  CAS  PubMed  Google Scholar 

  56. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB . Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.

    Article  CAS  PubMed  Google Scholar 

  57. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21: 1653–1659.

    Article  PubMed  Google Scholar 

  58. Windsor PM, Nicol KF, Potter J . A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004; 101: 550–557.

    Article  PubMed  Google Scholar 

  59. Ngo TH, Barnard RJ, Leung PS, Cohen P, Aronson WJ . Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology 2003; 144: 2319–2324.

    Article  CAS  PubMed  Google Scholar 

  60. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ . Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 2002; 13: 929–935.

    Article  PubMed  Google Scholar 

  61. Leung PS, Aronson WJ, Ngo TH, Golding LA, Barnard RJ . Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro. J Appl Physiol 2004; 96: 450–454.

    Article  CAS  PubMed  Google Scholar 

  62. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA . A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate 2003; 56: 201–206.

    Article  PubMed  Google Scholar 

  63. Barnard RJ, Leung PS, Aronson WJ, Cohen P, Golding LA . A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer. Eur J Cancer Prev 2007; 16: 415–421.

    Article  CAS  PubMed  Google Scholar 

  64. Ji LL . Exercise at old age: does it increase or alleviate oxidative stress? Ann NY Acad Sci 2001; 928: 236–247.

    Article  CAS  PubMed  Google Scholar 

  65. Ji LL . Exercise-induced modulation of antioxidant defense. Ann NY Acad Sci 2002; 959: 82–92.

    Article  CAS  PubMed  Google Scholar 

  66. Ji LL . Modulation of skeletal muscle antioxidant defense by exercise: role of redox signaling. Free Radic Biol Med 2008; 44: 142–152.

    Article  CAS  PubMed  Google Scholar 

  67. Ji LL, Gomez-Cabrera MC, Vina J . Exercise and hormesis: activation of cellular antioxidant signaling pathway. Ann NY Acad Sci 2006; 1067: 425–435.

    Article  CAS  PubMed  Google Scholar 

  68. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR . Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol 2005; 98: 1534–1540.

    Article  PubMed  Google Scholar 

  69. Fairey AS, Courneya KS, Field CJ, Mackey JR . Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions. Cancer 2002; 94: 539–551.

    Article  PubMed  Google Scholar 

  70. Nieman DC, Cook VD, Henson DA, Suttles J, Rejeski WJ, Ribisl PM et al. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int J Sports Med 1995; 16: 334–337.

    Article  CAS  PubMed  Google Scholar 

  71. McTiernan A . Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008; 8: 205–211.

    Article  CAS  PubMed  Google Scholar 

  72. Bokov A, Chaudhuri A, Richardson A . The role of oxidative damage and stress in aging. Mech Ageing Dev 2004; 125: 811–826.

    Article  CAS  PubMed  Google Scholar 

  73. Sies H . Oxidative stress: from basic research to clinical application. Am J Med 1991; 91 (3C): 31S–38S.

    Article  CAS  PubMed  Google Scholar 

  74. Savage PA, Vosseller K, Kang C, Larimore K, Riedel E, Wojnoonski K et al. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Science 2008; 319: 215–220.

    Article  CAS  PubMed  Google Scholar 

  75. Kottke T, Sanchez-Perez L, Diaz RM, Thompson J, Chong H, Harrington K et al. Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res 2007; 67: 11970–11979.

    Article  CAS  PubMed  Google Scholar 

  76. Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM . Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res 2008; 68: 861–869.

    Article  CAS  PubMed  Google Scholar 

  77. Degl’Innocenti E, Grioni M, Capuano G, Jachetti E, Freschi M, Bertilaccio MT et al. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells. Cancer Res 2008; 68: 292–300.

    Article  CAS  PubMed  Google Scholar 

  78. Andreani V, Gatti G, Simonella L, Rivero V, Maccioni M . Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo. Cancer Res 2007; 67: 10519–10527.

    Article  CAS  PubMed  Google Scholar 

  79. Zheng X, Cui XX, Huang MT, Liu Y, Shih WJ, Lin Y et al. Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice. Oncol Rep 2008; 19: 1583–1588.

    PubMed  PubMed Central  Google Scholar 

  80. Potter MQ, Freedland SJ, Poulton S, Dewhirst M, Jones LW . Effects of voluntary wheel running on prostate cancer growth and progression in LAPC-4 xenografts. Proceedings of the 99th Annual Meeting of the American Association for Cancer Research 2008.

  81. Doyle C, Kushi LH, Byers T, Courneya KS, Demark-Wahnefried W, Grant B et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2006; 56: 323–353.

    Article  PubMed  Google Scholar 

  82. Carroll P, Carducci MA, Zietman AL, Rothaermel JM . Report to the nation on prostate cancer: a guide for men and their families. Retrieved December 5, 2008, from The Prostate Cancer Foundation Web site: http://www.prostatecancerfoundation.org/site/c.itIWK2OSG/b.1190693/k.632D/Patient_Guide_Contents.htm

  83. Lu-Yao G, Stukel TA, Yao SL . Changing patterns in competing causes of death in men with prostate cancer: a population based study. J Urol 2004; 171 (6 Part 1): 2285–2290.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urologic Surgery, Department of Surgery, Duke Prostate Center, Duke University Medical Center, Durham, NC, USA

    J Antonelli & S J Freedland

  2. Department of Surgery, Durham VA Medical Center, Durham, NC, USA

    S J Freedland

  3. Department of Pathology, Duke University Medical Center, Durham, NC, USA

    S J Freedland

  4. Department of Surgery, Duke University Medical Center, Durham, NC, USA

    L W Jones

Authors
  1. J Antonelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S J Freedland
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L W Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L W Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antonelli, J., Freedland, S. & Jones, L. Exercise therapy across the prostate cancer continuum. Prostate Cancer Prostatic Dis 12, 110–115 (2009). https://doi.org/10.1038/pcan.2009.4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2009.4

Keywords

This article is cited by

Search

Advanced search

Quick links